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avian influenza A(H5N1) virus, for which only 2 of the se-
rum specimens we tested were positive (data not shown), 
but much lower than the seropositivity level for low 
pathogenicity avian influenza A(H9N2) virus; 3.4% of the 
samples tested were positive for A/Chicken/Hong Kong/
G9/1997(H9N2)–like virus (data not shown). A previous 
US study has reported H6N2-positive antibodies in veteri-
narians (9). Our results and the veterinarian study indicate 
that the H6N2 virus could infect humans. 
In our study, positive samples were detected in 19 of 
22 provinces and in all tested worker populations, suggest-
ing that the H6 virus has been broadly circulating in birds 
in China. Live poultry market exposure is the major risk 
factor for human infection with avian influenza H6 virus. 
The limitation of this study is that antigen selection may 
not accurately detect neutralization antibodies for differ-
ent subtypes of H6 viruses. Surveillance of the H6 virus 
in birds and occupationally exposed populations should be 
strengthened for pandemic preparedness.
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To the Editor: Middle East respiratory syndrome 
coronavirus (MERS-CoV) was first identified among hu-
mans in 2012 in Saudi Arabia (1). As of February 5, 2015, 
a total of 971 MERS cases and 356 associated deaths had 
been confirmed (2). Because MERS is a zoonotic disease, it 
is essential that the animal reservoirs and hosts that sustain 
virus circulation in nature be identified.
Seroepidemiologic and virologic studies have dem-
onstrated evidence of MERS-CoV infection in dromedary 
camels (Camelus dromedarius) in the Arabian Peninsula 
(3), and viruses isolated from dromedaries appear capable 
of infecting the human respiratory tract (4). In some in-
stances, MERS-CoV infection in dromedaries has preced-
ed infection in humans (5), indicating that dromedaries 
are a natural host for MERS-CoV and a possible source 
of human infection. Thus, it is important to define the 
geographic range of MERS-CoV infection in camels and 
the species of camelids that are infected by MERS-CoV 
in nature.
Two species of camels exist: 1-hump dromedaries (C. 
dromedarius) and 2-hump Bactrian camels (C. bactrianus). 
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Dromedaries are common in hot desert terrains of the Ara-
bian Peninsula, the Middle East, Afghanistan, central Asia, 
India, and parts of Africa. Bactrian camels are found in cold-
er steppes of Mongolia, Central Asia, Pakistan, and Iran. 
Studies have demonstrated a high seroprevalence (>90%) of 
MERS-CoV in adult (>5 years of age) dromedaries from the 
Middle East and from northern, eastern, and parts of central 
Africa (6), but whether MERS-CoV circulates among Bac-
trian camels is unknown. 
To determine whether MERS-CoV is circulating 
among both species of camels, we studied apparently 
healthy Bactrian camel herds in southern Mongolia dur-
ing November 24–30, 2014. We investigated 11 herds in 
Umnugovi Province (170 sampled animals) and 1 herd 
in the adjacent Dundgovi Province (30 sampled animals) 
(Table). A convenience sample was collected from each 
herd; younger animals were oversampled. Serum and na-
sal swab samples were collected from each animal. The 
nasal swab samples were placed in virus transport me-
dium and later tested by real-time PCR targeting open-
reading frame 1a and upstream of envelope protein gene, 
as previously described (7); all samples were negative for 
MERS-CoV RNA. The serum samples were tested for the 
presence of MERS-CoV antibody by using a validated 
MERS-CoV (strain EMC) spike pseudoparticle neutral-
ization test (8); no samples were positive, indicating a 
lack of recent or past MERS-CoV infection. A random 
sample of 5 serum samples each from camels in Umnu-
govi and Dundgovi Provinces was tested by using a mi-
croneutralization test against bovine coronavirus (BCoV) 
as previously described (8); all 10 samples were positive 
(titer range 1:20–1:640).
The sampled animals included 127 camels >5 years 
of age from 12 herds across 2 provinces in southern 
Mongolia. Thus, the negative test results indicate that 
MERS-CoV is not circulating among Bactrian camels in 
southern Mongolia. The seroprevalence of MERS-CoV 
among adult dromedaries in the Middle East and Africa 
is typically >90%, so the lack of any serologic reactiv-
ity in camels from Mongolia implies that MERS-CoV 
infection does not infect Bactrian camels or that the geo-
graphic range of the virus does not extend to northeast-
ern Asia. In contrast, infection with a BCoV-like coro-
navirus seems ubiquitous in Bactrian camels, as it is in 
dromedaries (7).
Dipeptidyl peptidase-4 (DPP4; cluster of differentia-
tion 26) is the receptor for MERS-CoV. As deduced from 
the human DPP4–MERS-CoV spike protein structural 
model, the differences in the amino acids in DPP4 mol-
ecules of dromedary and Bactrian camel were found in 2 
small regions far from the binding interface of DDP4 and 
MERS spike protein (9). The 15 aa of DPP4 critical for 
binding with MERS-CoV spike protein are conserved be-
tween dromedaries and Bactrian camels. Definitive evi-
dence of susceptibility, or lack thereof, of Bactrian camels 
to MERS-CoV can be established only by experimental 
infection of these animals.
Even if Bactrian camels are susceptible to MERS-
CoV infection, geographic separation may be an alterna-
tive explanation for the absence of MERS-CoV among 
camels in Mongolia. So far, Australia is the only country 
where dromedaries appear to be free of MERS-CoV; how-
ever, as with dromedaries elsewhere, dromedaries in Aus-
tralia are infected by a BCoV-like virus (8). Dromedaries 
in Australia originated from Afghanistan; these camels 
were shipped to Australia in the early part of the twen-
tieth century to work on railroad construction projects. 
There are 2 plausible explanations for the lack of MERS-
CoV in Australia: the small numbers of adult animals that 
were transported from Afghanistan to Australia might not 
have been sufficient to introduce the virus into Austra-
lia or the virus might have been absent from dromedaries 
in Afghanistan.
Our study was limited by sample size and by the 
breadth of the study area. Mongolia has 21 provinces and 
≈349,300 Bactrian camels, but we studied just 2 southern 





Table. Collection sites of nasal swab and serum specimens from Bactrian camels tested for Middle East respiratory syndrome 
coronavirus, southern Mongolia, November 2014 
Herd no. Province, district 
Age, y 
No. sampled/no. total in herd <1 2–4 >5 
1 Umnugovi, Khankhongor 9 5 9 23/56 
2 Umnugovi, Khankhongor 7 2 9 18/31 
3 Umnugovi, Khankhongor 8 0 5 13/28 
4 Umnugovi, Khankhongor 0 9 17 26/65 
5 Umnugov, Bayan-Ovoo 0 7 8 15/27 
6 Umnugovi, Bayan-Ovoo 0 1 16 17/70 
7 Umnugovi, Bayan-Ovoo 0 0 4 4/9 
8 Umnugovi, Bayan-Ovoo 0 2 9 11/33 
9 Umnugovi, Bayan-Ovoo 0 0 10 10/54 
10 Umnugovi, Bayan-Ovoo 1 5 7 13/36 
11 Umnugovi, Bayan-Ovoo 0 8 12 20/24 
12 Dundgovi, Khuld 0 9 21 30/58 
Total  25 48 127 200/491 
 
provinces and a total of 200 camels. Umnogovi Province 
has the largest, and Dundgovi Province the fifth largest, 
camel population in the country (≈113,000 and ≈28,000 
animals, respectively). Further studies on the epidemiol-
ogy of MERS-CoV infection in dromedaries and Bactrian 
camels from central Asia, China, and Mongolia are war-
ranted.
The field work for this study was supported by a research 
grant from The University of Hong Kong; the laboratory 
testing was supported by the National Institutes of Health, 
National Institute of Allergy and Infectious Diseases (contract 
N272201400006C).
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To the Editor: Oligella ureolytica is an aerobic gram-
negative coccobacillus found as a commensal organism in 
human urinary tracts (1). Previously referred to as CDC 
Group IVe, this bacterium is not commonly encountered 
as a source of infection and is difficult to isolate by using 
conventional laboratory procedures (2). The few cases of 
pathogenic infection with O. ureolytica described in the lit-
erature have occurred in patients ranging in age from new-
born to 89 years and from the varied locations of India, 
Turkey, Canada, and the United States (3–7). We report a 
case of O. ureolytica bacteremia in a patient in whom sep-
sis was diagnosed and review the current literature on this 
emerging pathogen.
A 66-year-old woman sought treatment in our emer-
gency department for a fever of 100.7°F, femur fracture, 
and a right buttock stage III decubitus ulcer. She reported 
having fallen 4 days earlier, after which she was unable to 
walk and spent 4 days laying in her own urine and feces. 
Blood tests revealed an elevated leukocyte count of 24.4 
× 109 cells/L (76% neutrophils, 2% bands), and urinalysis 
showed trace leukocyte esterase, +3 bacteria, and 5–10 leu-
kocytes. Chest radiograph and head computed tomography 
images were unremarkable. Her electrocardiogram showed 
nonspecific ST wave changes. Samples from the patient’s 
blood, urine, and wounds were collected while the patient 
was in the emergency department and were sent for culture.
Wound cultures showed growth of Proteus mirabilis 
and Enterococcus spp. The urine culture grew >100,000 
CFU Escherichia coli. The first set of blood cultures 
grew O. ureolytica in aerobic and anaerobic bottles, but 
another set drawn 30 min later showed no growth. The 
blood cultures were processed by using the Bact/Alert 3D 
(bioMérieux, Marcy l’Etoile, France) and Gram stained. 
Identification was from the Vitek 2 compact system (bio-
Mérieux). The O. ureolytica sample was sensitive to ami-
kacin, ampicillin/sulbactam, ceftazidime, ceftriaxone, 
gentamicin, imipenem, levofloxacin, nitrofurantoin, tri-
methoprim/sulfamethoxazole, and chloramphenicol. No 
resistance was found.
Because of the unique bacteremia, further diagnostics 
were conducted. The results of chest, abdomen, and pel-
vic computed tomography scans were unremarkable. HIV 
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